Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
February 1st 6:30 AM EST
https://allogeneic-cell-therapies-europe.com/whats-on/day-two/
February 15th Plurinuva !!!
https://www.meatevo.com/attendees
Drug Addiction Treatment Market To Reach USD 31.17 Billion By 2027
https://pubmed.ncbi.nlm.nih.gov/35890207/
January 18th 10:30 AM EST
https://advancedtherapiesweek.phacilitate.com/stream/disruptive-automation-technologies-closed-systems-and-mechanizing-the-workflow/
January 19th PLURI CEO AND CFO ARE IN AUSTIN, TEXAS
https://legacy.pluristem.com/news-and-events/iac-national-summit/
GIDDY-UP !!!
China and U.S. Discuss Best Regulatory Processes for Cultivated Meat
https://www.greenqueen.com.hk/china-us-regulatory-processes-for-cultivated-meat/
Pluri is actively exploring new partnerships and poised to capitalize on further collaborations in
the year ahead.
https://legacy.pluristem.com/wp-content/uploads/2021/06/Pluri_CEO_Letter_FINAL_FOR_RELEASE_isa.pdf
Breaking News !!! New CLI & Connective Tissue Patent Published December 1st, 2022 !!!
PLURI Must Have Discovered That Combining Placenta & Adipose Cells Is Much More Effective For Treating A Number Of Indications.
VERY EXCITING NEWS !!!
SUMMARY OF THE INVENTION:
[0022] According to an aspect of some embodiments of the present invention there is provided a method of treating ischemia in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of adherent cells of a tissue selected from the group consisting of a placenta and an adipose tissue, thereby treating the ischemia in the subject.
[0023] According to an aspect of some embodiments of the present invention there is provided a method of treating a medical condition requiring connective tissue regeneration and/or repair in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of adherent cells of a tissue selected from the group consisting of a placenta and an adipose tissue, thereby treating the medical condition requiring connective tissue regeneration and/or repair in the subject.
https://worldwide.espacenet.com/patent/search/family/040118825/publication/US2022378847A1?q=pn%3DIL272587B
This Will Benefit PLURI In A Big Way !!! This Bill Is On It's Wat To Be Signed By The President !!! Hello PLX-R18 !!!
Passed Senate (09/29/2022) FDA Modernization Act 2.0
This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.
The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.
https://www.congress.gov/bill/117th-congress/senate-bill/5002
Pluri CEO Issues Letter to Shareholders Summarizing the Strategy Change and Progress in 2022 and Announcing Food Tech Joint Venture
Proof of Concept
https://legacy.pluristem.com/wp-content/uploads/2021/06/Pluri_CEO_Letter_FINAL_FOR_RELEASE_isa.pdf
British Doctors Save Baby's Life In 'World-First' Repairing Of Heart Using Placenta Stem Cells
https://www.ndtv.com/feature/british-doctors-save-babys-life-in-world-first-repairing-of-heart-using-placenta-stem-cells-3626690
Israel’s biggest food maker enters JV to put ‘affordable cultured food on the table’
https://www.foodnavigator.com/Article/2022/01/18/Tnuva-JV-with-Pluristem-to-serve-up-affordable-cultured-food-in-2023
Pluri Prices $8.2 million Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
HAIFA, Israel, December 15, 2022 – Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a
leading biotechnology company, announced today that it has signed securities purchase agreements
with domestic and non-U.S. investors for the sale of an aggregate of 7,885,900 of the Company’s
common shares and warrants to purchase up to an aggregate of 7,885,900 of the Company’s common
shares. On December 13, 2022, the Company executed securities purchase agreements to sell, at a
purchase price of $1.03 per share, up to 5,579,883 of the Company’s common shares and warrants to
purchase up to 5,579,883 of the Company’s common shares, with an exercise price of $1.03 per share
and a term of three years. On December 14, 2022, the Company executed securities purchase
agreements to sell, at a purchase price of $1.05 per share, up to 2,068,517 of the Company’s common
shares and warrants to purchase up to 2,068,517 of the Company’s common shares, with an exercise
price of $1.05 per share and a term of three years. On December 15, 2022, the Company executed
securities purchase agreements to sell, at a purchase price of $1.06 per share, up to 237,500 of the
Company’s common shares and warrants to purchase up to 237,500 of the Company’s common shares,
with an exercise price of $1.06 per share and a term of three years. The warrants sold in the offerings
will be exercisable upon the later of six months from their issuance date, or until the Company increases
its authorized shares. In addition, Yaky Yanay, the Company’s Chief Executive Officer, has committed to
forgo $375,000 of his annual cash salary for the next twelve months in return for equity grants issuable
under the Company’s existing equity compensation plans. The offerings are expected to close by January
31, 2023.
The offerings are being made in the United States pursuant to the exemption from securities
registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 of
Regulation D as promulgated by the Securities and Exchange Commission (the "SEC"). The securities
have not been registered under the Securities Act of 1933, as amended, or applicable state securities
laws, and accordingly may not be offered or sold in the United States absent registration with the SEC or
an applicable exemption from such registration requirements.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there
be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such state or
jurisdiction.
That Is Absolutely Right !!! You're Learning...Slowly !!!
WOW !!! IMO...This Is A Biggie !!!
https://worldwide.espacenet.com/patent/search/family/078467889/publication/WO2021224920A1?q=pn%3DWO2021224920
You Have Much To Learn Sekander....IMO...You Will Become Educated Soon !!!
Monday, December 12, 2022, 6:00 PM-8:00 PM
https://ash.confex.com/ash/2022/webprogram/Paper169266.html
The United Arab Emirates and Israel ratified a comprehensive economic partnership agreement on Sunday, UAE Foreign Trade Minister Thani bin Ahmed Al Zeyoudi announced.
The UAE-Israel Comprehensive Partnership Agreement has now been ratified by both governments. This deal will eliminate or reduce tariffs on 96% of products, providing a major boost to our industrial and service sectors.
https://www.jpost.com/business-and-innovation/all-news/article-724627
Jaime...This Stock WilL NEVER Be Delisted !!! The Biggest Worry This Low Stock Price Brings Is A Hostile Take-Over Attempt !!! I'm Very Worried About That Right Now... If Some Entity Swoops In And Buys 17 Million Shares For Less Than $ 40.00 !!! That Would Be A VERY BAD SITUATION IMO.
Monday, December 12, 2022, 6:00 PM-8:00 PM
https://ash.confex.com/ash/2022/webprogram/Paper169266.html
PAGE 11
Directs the Secretary of Defense to provide support for bio-industrial manufacturing
facilities to conduct research and development to support national security or secure
fragile supply chains.
PAGE 15
Building Supply Chain and Stockpile Resilience
? Authorizes $1 billion for the National Defense Stockpile to acquire strategic and
critical materials required to meet the defense, industrial, and essential civilian needs
of the United States.
? Requires the National Defense Stockpile Manager to submit a briefing on strategic and
critical materials shortfalls.
https://www.armed-services.senate.gov/imo/media/doc/fy23_ndaa_agreement_summary.pdf
Believer Meats Breaks Ground on U.S. Cultured Meat Plant
Claims it will be the largest cultivated meat production facility in the world.
https://www.foodprocessing.com/ingredients/animal-proteins/news/21438687/believer-meats-breaks-ground-on-us-cultured-meat-plant
The DoD Prophylactic Injection of PLX-R18 In Mice Showed Very Good Results !!!
https://www.mdpi.com/2073-4425/13/10/1756
Reported herein are the final encouraging safety and efficacy results from a phase 1 study (NCT03002519).
https://ash.confex.com/ash/2022/webprogram/Paper169266.html
Sweet Tweet !!!
https://twitter.com/Pluribiotech
What does FDA’s greenlight of cultivated meat mean for Europe? ‘There are worldwide implications’
https://www.foodnavigator.com/Article/2022/11/30/what-does-fda-s-greenlight-of-cultivated-meat-mean-for-europe-there-are-worldwide-implications